CoreAge Rx vs TeleClinic
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and TeleClinic head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make TeleClinic a bad call — it's best for readers comparing first-month offers who will obtain a medication-specific renewal price and the written price-lock conditions before enrollment. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | TeleClinic |
|---|---|---|
| Brief Score | 94/100 (A) | 75/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm ongoing renewal price Introductory $79 first month or $179 for first three months; generic price-lock terms differ. Full price detailsCompounded semaglutide offered; current renewal quote unknown; earlier listing: From $199/mo (compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm ongoing renewal price Introductory $149 first month or $399 for first three months; generic price-lock terms differ. Full price detailsCompounded tirzepatide offered; current renewal quote unknown; earlier listing: From $299/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | 47 states advertised; medication-specific state eligibility requires confirmation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
TeleClinic: Current introductory offers differ from the generic price-lock table. Confirm the medication-specific renewal quote; earlier $199/$299 observations are historical.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.